Roger Lane

Rivastigmine for Dementia Associated with Parkinson's Disease

Murat Emre, Dag Aarsland, Alberto Albanese et al. · New England Journal of Medicine · 2004 · 1.2K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study

Howard Feldman, Steven H. Ferris, Bengt Winblad et al. · The Lancet Neurology · 2007 · 337 citations

Medicine, Neurology, Pharmacology +14

Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial

Catherine J. Mummery, Anne Börjesson‐Hanson, D. Blackburn et al. · Nature Medicine · 2023 · 318 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease

David J. Burn, Murat Emre, Ian G. McKeith et al. · Movement Disorders · 2006 · 308 citations

Medicine, Neurology, Pharmacology +17

A six‐month double‐blind, randomized, placebo‐controlled study of a transdermal patch in Alzheimer's disease–– rivastigmine patch <i>versus</i> capsule

Bengt Winblad, Jeffrey L. Cummings, Niels Andreasen et al. · International Journal of Geriatric Psychiatry · 2007 · 284 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14